Agoracom Blog Home

Posts Tagged ‘$TSXV’

« Older Entries
Newer Entries »

Lexaria Announces Name Change of PoViva Tea to ViPova(TM) Tea, and Provides Information on Hemp-Based Industry

Posted by AGORACOM-JC at 11:14 AM on Wednesday, December 17th, 2014

Kelowna, British Columbia–(December 17, 2014) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) announces that, effectively immediately, it’s 51%-owned company formerly known as PoViva Tea, will now operate with the trade name of ViPovaâ„¢ Tea. Selling our products under the name of ViPovaâ„¢ is a branding strategy undertaken to ensure long term protection of intellectual rights.

The name change does not affect ownership, operational or any other material issues. However the name change has delayed the product launch by 1-2 weeks, so that ViPovaâ„¢ Tea is now expected to be available to be ordered by consumers around the first week of January.

Both Lexaria and ViPovaâ„¢ also wish to clarify some important distinctions about the Cannabidiol(CBD)-from-hemp industry within which ViPovaâ„¢ operates. Hemp based CBD is legal in all 50 states, as are hemp-based food products that can be purchased from national retailers like Whole Foods or Costco, and many regional food stores. Popular hemp food products include hemp cereal, seeds, milk, and oil.

Hemp based products contain very low thresholds of Tetrahydrocannabinol (THC) below government-imposed limits of less than 0.3%. At the same time, the CBD within hemp is NOT psychoactive and does not create feelings of euphoria. Hemp is grown legally in countries like Canada, England, New Zealand and parts of Europe, and is legally imported into the USA from these and other countries.

ViPovaâ„¢ uses only legal CBD oil extracts, grown from legal hemp in nations where it is legal to do so, in ViPovaâ„¢-branded tea. ViPovaâ„¢ uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPovaâ„¢ has this ground-breaking technology for CBD/lipid infusion.

ViPovaâ„¢ has not entered, and has no plans to enter, the medical marijuana market whether located within the USA or in any other country. ViPovaâ„¢ is building a new company and product line focused exclusively on legal CBD products, which at this time are available only within the United States.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPovaâ„¢ products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Tags: , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Announces Name Change of PoViva Tea to ViPova(TM) Tea, and Provides Information on Hemp-Based Industry

INTERVIEW: Stria Lithium Discusses Revolutionary Lithium Processing Technology

Posted by AGORACOM-JC at 10:06 AM on Wednesday, December 17th, 2014

SRA: TSX-V

WATCH INTERVIEW NOW!

  • Focused on the emerging green energy revolution, with a particular focus on Lithium.
  • Aiming to become one of the lowest cost producers in the world for battery- grade technology lithium through partnerships, licensing and joint ventures which are critical for high-technology green energy industries such as consumer electronics, energy storage and military.
  • Unveiled lithium procession technology that will provide the company with significant advantages.

Hub On AGORACOM / Corporate Website / Watch Interview Now!

Tags: , , , , , , ,
Posted in All Recent Posts, Stria Lithium | Comments Off on INTERVIEW: Stria Lithium Discusses Revolutionary Lithium Processing Technology

Mazorro Provides Update on GrowPros MMP Activities

Posted by AGORACOM-JC at 8:36 AM on Wednesday, December 17th, 2014

OTTAWA, ONTARIO–(Dec. 17, 2014) – Mazorro Resources Inc. (the “Company“) (CSE:MZO)(FRANKFURT:JAM) announces that, further to its press release November 6, 2014 announcing the signature of a definitive agreement with GrowPros MMP Inc. (“GrowPros“) and in anticipation of a successful closing of the proposed amalgamation (“Amalgamation“), management of GrowPros has provided the following update on its activities.

GrowPros is finalizing the second revision to its application for a license under the Marihuana for Medical Purposes Regulations (“MMPR“). These revisions are part of the normal review process and GrowPros is impressed by the expediency with which its file has been reviewed by Health Canada. In addition, GrowPros will be closing the previously-announced transaction for the purchase of 190 acres of agricultural land located 45 minutes North of Ottawa, Ontario which will house a 50,000 sq. ft. production facility with unlimited room for expansion. As a result, management of GrowPros advises that it expects to receive a ready to build authorization from Health Canada in the second quarter of 2015.

GrowPros also reports that it is currently in preliminary negotiations with companies in various service and supply segments of the cannabis production industry. Management of GrowPros advises that merging main stream business into the cannabis industry will be a major focus of GrowPros going forward. Accordingly, these opportunities should provide a higher return on investment for GrowPros and, ultimately, a quicker route to profitability than solely being an applicant or licensed MMPR producer. This is in line with GrowPros‘ philosophy as a medical marihuana consultation and acquisition firm.

As previously announced on December 3, 2014, the Company would like to remind shareholders that the special meeting of the Company’s shareholders to approve the (i) proposed change of business from mineral resource exploration to the medical marijuana industry and (ii) change of name to “GrowPros Cannabis Inc. / Entreprise GrowPros cannabis inc.” will be held on December 29, 2014 (the “Special Meeting“). A notice of meeting, management information circular, and form of proxy in respect of the Special Meeting has been sent to shareholders and is available under the Company’s profile on the CSE website and on SEDAR.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to complete the Amalgamation and change of business, failure to obtain sufficient financing, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Any forward-looking statement speaks only as of the date on which it is made and except as may be required by applicable securities laws. The Company disclaims any intent or obligation to update any forward-looking statement.

Mazorro Resources Inc.
André Audet
Interim President, CEO, and CFO
(613) 241-2332

Tags: , , , , ,
Posted in GrowPros Cannabis Inc., Medical Marijuana Stocks | Comments Off on Mazorro Provides Update on GrowPros MMP Activities

Quebec Quartz Assay Results Surpass Expectations, Validated as Suitable for Silicon Metal and High Purity Quartz Applications

Posted by AGORACOM-JC at 8:08 AM on Tuesday, December 16th, 2014

Montreal, Quebec / December 16, 2014, / Uragold Bay Resources Inc. (“Uragold”) (TSX Venture: UBR) is pleased to announce that it’s wholly owned subsidiary, Quebec Quartz, has received assay results for samples taken on the Roncevaux Quartz (Silica) property located in the Matapedia valley in the Gaspe region of Quebec.

The corrected SiO2 average for the 20 samples assayed is 99.65%, ranging from 99.37% to 99.86%. These results validate the fact that the Quartz material from the Roncevaux Property would make suitable feedstock for Silicon Metal production and applications requiring high purity quartz.

Patrick Levasseur, President and COO of Uragold stated, “We are extremely happy with these results, they have surpassed our initial expectations and validated our decision to focus on our Ronceveaux property since it is situated within 80 kilometers from a deep-sea harbour that can handle bulk shipments for worldwide exports, less then 300 Km from the future FerroAtlantica Port Cartier Silicon Metal production facilities and less then 500 Km Globe Specialty Metals Becancour silicon metal production facilities.”

In 2003, an exploration potential of ? 400,000 tons of SiO2 was calculated using the 360 m surface length of the Quartz vein, its average width (between 3 m and 12m) and assuming a continuation up to 50 M of depth. (GM60610: Barrette, Jean-Paul. 2003. Rapport des travaux d’exploration miniere sur la veine de quartz pur. Projet Silice Roncevaux, Canton Roncevaux, Gaspesie).

IMPORTANCE OF QUARTZ (SILICA)

Quartz (SiO2) is one of the most abundant minerals. It occurs in many different settings throughout the geological record. However, high Purity Quartz deposits with low impurities are rare and only a few deposits are suitable in volume, quality and amenability to be tailored to refining methods for specialty high purity applications.

High Purity Quartz (HPQ), and Silicon Metal is used in large part in the aluminum industry while Ultra High Purity Quartz (UHPQ) has become one of today’s key strategic minerals with applications in high-tech industries that include semiconductors, LCD displays, fused quartz tubing, microelectronics, solar silicon applications and recently, Silicon Anode Lithium Batteries.

GO FORWARD PLAN:

The Corporation intends to advance the development of the Roncevaux project by completing the following steps during Q1 & Q2 2015:

  1. 1.Send material to specialized laboratories to find the best beneficiation process to transform the Roncevaux Quartz material into Ultra High Purity Quartz for advanced material and pharmaceutical applications.

High Purity Quartz beneficiated to 99.998% Si02 can command prices up to
US$ 6,000/T (Source: Dorfner Anzaplan). The Corporation intends to focus its interest on this segment of the market.

Quartz for Silicon Metal the sales price averages between US$ 100/T to US$ 250/T.

  1. 2.Send quartz samples to Silicon Metals and other material buyers.

Multiple end-users have approached the Corporation. Having now received our own lab results, the Corporation is ready to start direct discussion with interested parties.

  1. 3.Evaluating the Property Potential.

The exact volume of the quart vein systems found on the Roncevaux Property needs to be confirmed and measured; and quartz occurrences contained in the new claims staked by Quebec Quartz after the first work programme need to be explored.

Mr. Levasseur added, “2015 will be an exciting year as we continue to develop Quebec Quartz’s exciting high purity silica projects while developing two gold mines in the Beauce region of Quebec.”

PARTIAL TABLE OF RESULTS:

Report Number: A14-09140
Analyte Symbol SiO2 Al2O3 Fe2O3(T) LOI Total SiO2
Unit Symbol % % % % % Corrected
Detection Limit 0.01 0.01 0.01 0.01 for lost
Analysis Method FUS-XRF FUS-XRF FUS-XRF FUS-XRF FUS-XRF Carbonate
41962 98.46 0.02 0.02 0.12 98.64 99.82%
41962-B 98.67 0.15 0.03 0.12 99.00 99.67%
41963 98.59 0.07 0.02 0.18 98.88 99.71%
41963-B 98.57 0.17 0.03 0.28 99.11 99.46%
41964 99.37 0.25 0.02 0.19 99.88 99.49%
41964-B 98.76 < 0.01 0.01 0.15 98.95 99.81%
41965 98.99 0.16 0.01 0.15 99.34 99.65%
41965-B 98.82 0.13 0.02 0.18 99.18 99.64%
41966 99.85 0.10 0.03 0.17 100.20 99.65%
41966-B 99.07 0.04 0.01 0.22 99.37 99.70%
41967 98.47 0.04 0.01 0.16 98.70 99.77%
41967-B 99.32 0.29 0.08 0.17 99.92 99.40%
41968 100.23 0.08 0.01 0.17 100.50 99.73%
41968-B 99.92 0.17 0.04 0.16 100.30 99.62%
41969 98.72 0.25 0.02 0.22 99.31 99.41%
41969-B 98.00 0.26 0.05 0.23 98.62 99.37%
41970 100.16 < 0.01 0.01 0.16 100.30 99.86%
41970-B 100.38 < 0.01 0.02 0.16 100.60 99.78%
41971 99.96 0.03 0.01 0.15 100.20 99.76%
41971-B 99.87 < 0.01 0.02 0.14 100.10 99.77%
Average 99.21 0.14 0.02 0.17 99.56 99.65%

The average losses in ignition (“LOI”) (material and moisture burned off during the assays) for the 20 samples is 0.17% (ranging between 0.12% and 0.23%) this suggest that a certain percentage of the alkali metals are present as a carbonate molecule, and with an average laboratory total of 99.55% (ranging between 98.88 % and 100.6%), a correction for the lost of carbonate is required in order to present the actual SiO2 grade of the samples.

Assay results confirm that the material is low to very low in all the major contaminants: Al2O3 average: 0.14%, range from <0.01% to 0.29%, Fe2O3 average: 0.02%, range from 0.01% to 0.08%, Co3O4 all samples <0.005%, CuO all samples <0.005%, MnO all samples <0.001%, NiO 15 samples <0.003%, the rest ranging from 0.003% to 0.012%, MgO all samples <0.01%, CaO 18 samples <0.01%, Na2O all samples <0.01%, K2O 8 samples <0.01%, the rest ranging from 0.01% to 0.03%, TiO2 9 samples <0.01%, the rest 0.01%, P2O5 average: 0.02%, range from 0.01% to 0.04%, Cr2O3 all samples <0.01%, V2O5 all samples <0.003%.

The samples were taken over the historical quartz vein from parallel trenches along a 360 m long quartz vein that varied between 3 m and 12 m in width. Samples weighing approximately 10 kg each along with a 3 kg duplicate were bagged on site. Ten samples were taken from each site and the field crew brought back approximately 130 kg.

The material was first sent to the INRS (Institut National de la Recherche Scientifique) laboratory in Quebec City to be prepared for testing for High Purity Silica and Silicon Metal potential. 20 prepared samples (an original and a duplicate) were sent to the Activation Laboratories in Ancaster, Ontario for whole rock and trace elements (FUS X-Ray Fluorescence (“XRF”)) assay.


Click Image To View Full Size

Picture 1: Field sample from the Roncevaux Property, Sample # 41765 tested 99.65% SiO2


Click Image To View Full Size

Picture 2: Visible showing of the Quartz veins on the Roncevaux Property.

Mr. Robert Gagnon, P. Geo, is a Qualified Person as defined by National Instrument 43-101, supervised the preparation of the information in this news release.

All the information on exploration potential herewithin presented is historical in nature and while relevant, the information was obtained before the implementation of National Instrument 43-101 and as such does not meet National Instrument 43-101 reporting standards. The historical estimate should not be relied upon until the Company can confirm them.

About Quebec Quartz

Uragold 100 % wholly owned subsidiary, Quebec Quartz, by virtue of being a first mover into this market, succeeded in becoming the largest holder of distinct High Purity Quartz properties in Quebec. Quebec Quartz strategic portfolio of High Purity Quartz (+99.+% SiO2) deposits and closed silicon metal mines in Quebec represent a unique and valuable asset. Quebec’s Quartz aims to become a leading supplier of Ultra High Purity Quartz

About Uragold Bay Resources Inc.

Uragold Bay Resources is a TSX-V listed Gold and High Purity Quartz exploration junior focused on generating free cash flow from mining operations. Our business model is centered on developing mining projects suited for smaller-scale start-up, (Capex < C$10M), that will generate high yield returns (IRR > 50%). Uragold will reach these goals by developing Quebec’s first placer mine in 50 years, the Beauce Placer Project developing and, in partnership with Golden Hope Mines, the Bellechasse-Timmins Gold Deposit.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman and CEO
Patrick Levasseur, President and COO

Tel: (514) 846-3271

www.uragold.com

Tags: , , , ,
Posted in URagold Bay Resources | Comments Off on Quebec Quartz Assay Results Surpass Expectations, Validated as Suitable for Silicon Metal and High Purity Quartz Applications

Supreme Pharmaceuticals Completes Upgrades on Marijuana Greenhouse Facility and Awaits Pre-License Inspection by Health Canada – Video News Alert on InvestmentPitch.com

Posted by AGORACOM-JC at 11:08 AM on Monday, December 15th, 2014

Vancouver, British Columbia–(December 15, 2014) – Supreme Pharmaceuticals (CSE:SL) (OTC PINK: SPRWF), announced the completion of security and infrastructure upgrades at its hybrid greenhouse facility located in southern Ontario, and awaits pre-license inspection by Health Canada. The 342,000 square foot greenhouse, purchased in May 2014, is located in Kincardine.

InvestmentPitch.com has produced a “video news alert” which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter “Supreme” in the search box.

The company has spent approximately $4 million in upgrades to transform the out-of-use tomato greenhouse into a highly secured, state-of-the-art, automated marijuana facility. These upgrades include a level 9 security vault capable of storing up to $150 million of dried marijuana, a sophisticated digital security system including intrusion detection and visual surveillance, along with sanitation and automation systems, all of which have been designed and installed to meet or exceed regulatory requirements set by Health Canada.

The company and its management team have carefully planned the upgrades to provide an optimal environment to manufacture high quality, low-cost medical marijuana. If successful in obtaining the license to produce medical marijuana subsequent to the pre-license inspection, the company expects to immediately commence growing in its first completed phase of the Facility. Subsequent phases of the facility are expected to be built out later in 2015 which will increase the productive capacity of the facility.

John Fowler, Director of Operations, stated: “The construction thus far has been a massive undertaking for us. We are excited to move forward in the licensing process and stay on track with our goal of providing high-quality, low-cost medical marijuana in the coming months.”

The company recently closed the second tranche of its private placement, placing a total of 5.6 million units at $0.32 for gross proceeds of $1.8 million. Each unit consisted of one share and ½ a warrant, with each warrant exercisable at $0.50 for 2 years. Management believes this funding will take the company through the licensing stage and beyond.

In November, the company announced changes and additions to the management team, which it considered were the final pieces to ensure Supreme’s future success as a leader in the medical marijuana industry.

The shares are currently trading at $0.38, and with 76.2 million shares outstanding, the company is capitalized at $29 million. For more information, please visit the company’s website, www.supreme.ca, call 604-674-2191 or email [email protected].

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
[email protected]

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Medical Marijuana Stocks, Supreme Pharmaceuticals Inc | Comments Off on Supreme Pharmaceuticals Completes Upgrades on Marijuana Greenhouse Facility and Awaits Pre-License Inspection by Health Canada – Video News Alert on InvestmentPitch.com

Lexaria Closes 51% Acquisition of PoViva Tea, LLC

Posted by AGORACOM-JC at 4:39 PM on Friday, December 12th, 2014

Kelowna, British Columbia–(December 12, 2014) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is pleased to announce it has closed the 51% acquisition of Poviva Tea, LLC.

As the final part of the closing, Lexaria has issued 119,047 restricted common shares of the Company to each of the two founders of PoViva Tea, LLC.

All issued shares will be subject to a hold period, for any resale into the USA under Rule 144, of six months and one day. The share issuance is subject to normal regulatory approvals. The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that and cannabidiol-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). PoViva products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. 

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , ,
Posted in All Recent Posts, Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Closes 51% Acquisition of PoViva Tea, LLC

Supreme Completes Pre-License Upgrades at Kincardine Greenhouse

Posted by AGORACOM-JC at 9:22 AM on Friday, December 12th, 2014

VANCOUVER, BRITISH COLUMBIA–(Dec. 12, 2014) – Supreme Pharmaceuticals Inc. (the “Company”) (OTCBB:SPRWF) (CSE:SL) is pleased to report that the Company has completed the security and infrastructure upgrades at the hybrid industrial greenhouse facility in Kincardine, Ontario (the “Facility“) and is ready for the Health Canada pre-license inspection of the Facility.

Since the acquisition of the 342,000 sq. ft. facility in May 2014, the Company has spent approximately $4M in upgrades to transform the Facility from an out-of use tomato greenhouse to a highly secured, state-of-the-art, automated medical marijuana facility. These upgrades include a level 9 security vault capable of storing up to $150 million of dried marijuana, a sophisticated digital security system including intrusion detection and visual surveillance, as well as sanitation and automation, all which meets or exceeds the regulatory requirements set by Health Canada.

The Company and its management team have carefully planned the upgrades of the Facility to provide an optimal environment to manufacture high quality, low-cost medical marijuana. If successful in obtaining the license to produce medical marijuana subsequent to the pre-license inspection, the Company expects to immediately commence growing in its first completed phase of the Facility. Subsequent phases of the Facility are expected to be built out later in 2015 which will increase the productive capacity of the Facility. No date has been set yet for the Health Canada inspection.

John Fowler, the Company’s Director of Operations, stated: “The construction thus far has been a massive undertaking for us. We are excited to move forward in the licensing process and stay on track with our goal of providing high-quality, low-cost medical marijuana in the coming months.”

FORWARD-LOOKING INFORMATION

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and information relating to the obtaining of a grow license, as well as the Company’s corporate strategy. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and related regulations. Accordingly, readers should not place undue reliance on the forward‐looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Supreme Pharmaceuticals Inc.
Investor Relations
430 – 580 Hornby Street, Vancouver BC, V6C 3B6
(604) 674-2191
[email protected]
www.supreme.ca

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Medical Marijuana Stocks, Supreme Pharmaceuticals Inc | Comments Off on Supreme Completes Pre-License Upgrades at Kincardine Greenhouse

Robix Announces Proposed Unit Private Placement

Posted by AGORACOM-JC at 3:04 PM on Thursday, December 11th, 2014

LETHBRIDGE, ALBERTA–(Dec. 11, 2014) – Robix Alternative Fuels Inc. (“Robix” or the “Corporation”) (CSE:RZX) announced today that it intends to complete a non-brokered private placement offering of units at a price of $0.40 per unit for gross proceeds of up to $1,000,000. Each unit will consist of one common share and one-half of one common share purchase warrant. Each whole warrant will entitle the holder thereof to acquire one additional common share at a price of $0.60 per share for a period of one year after the closing.

A finder’s fee of up to 10% of the gross proceeds of the offering may be paid on all or any portion of the funds raised pursuant to this offering. In addition, finders will receive finders warrants equal to up to 10% of the number of units issued in connection with the offering. Each finders warrant will entitle the holder to purchase one common share at a price of $0.40 for a period of one year after the closing.

The closing of the offering is expected to occur on or about December 31, 2014, and is subject to regulatory approval. For further details on the offering, please contact the Corporation. All securities issued in connection with the offering will be subject to a hold period of four months from the date of closing. The net proceeds from the offering will be used to finance the Corporation’s continuing capital program and for general working capital purposes.

About Robix:

The Corporation is an “industrial products/technology” company, offering to investors a unique opportunity to participate in a leading company in the business of ownership of patents, and their development from commercialization to worldwide expansion through various business arrangements. Robix owns a Clean Ocean Vessel (“COV”) patent, which is an oil spill recovery vessel design with the capability to recover oil in rough and debris laden sea conditions. Robix has recognized a worldwide market opportunity for effective containment, recovery and disposal equipment, particularly in the oil spill protection industry, and it proposes to develop a business model as a service provider, and/or equipment provider under licensing agreements with other industry participants, wherein Robix will use its COV patented design solution.

No stock exchange or any securities regulatory body has reviewed the contents of this news release.

This news release may contain certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in the company’s disclosure documents on the SEDAR website at www.sedar.com. The Corporation does not undertake to update any forward-looking information except in accordance with applicable securities laws.

Robix Alternative Fuels Inc.
Nathan Hansen
President & CEO
250-683-8957
[email protected]

Robix Alternative Fuels Inc.
Robin Ray
Chief Financial Officer
403-327-3094
[email protected]
www.robixfuels.com

Tags: , , , , ,
Posted in Robix Alternative Fuels | Comments Off on Robix Announces Proposed Unit Private Placement

CLIENT FEATURE: QE2 Acquisition Corp. (QE: TSX-V) Revenue Generating Infrastructure Play Capitalizing on the Alberta Advantage

Posted by AGORACOM-JC at 4:11 PM on Wednesday, December 10th, 2014

Why Invest in QE2 Acquisition Corp.?

  • Aggressive Growth by Acquisition
  • $100M 2018 Growth Objective
  • $1.9M in 2013 Normalized EBITDA
  • Experienced, Proven, Driven Management Team

  • Calgary founded firm that acquires, consolidates and grows well managed, profitable, asset backed, Alberta-based businesse in the Infrastructure and Utility Services sectors

  • Recruiting the best expertise in the industry to run day to day operations as well as drive strategic vision

Recent Highlights

  • Signed a letter of intent to acquire a privately-owned accredited electrical contractor located in the Edmonton area (Read Release)
  • Pillar Contracting Ltd. has successfully bid and been awarded a contract by the City Of Calgary to continue the installation phase of 1,000 new LED streetlight heads (Read Release).

Company Portfolio

In April 2014, QE2 Acquisition Corp. completed the acquisition of key assets of Candesto Enterprises Inc.
 

CANDESTO ENTERPRISES LTD.

1450 Bearspaw Dam Rd NW, Calgary, AB T3L 0C3
p: 403-286-7922
About Candesto Enterprises Ltd.
Candesto is a leader in highway signage, guardrail installation services, and miscellaneous fencing with its services primarily engaged in the new construction of roads and highways. Candesto has operated for over 20 years and strategically concentrates its activities in southern Alberta, with the bulk of its customers acting as the project general contractor, working for 1 of the 4 levels of government.
 
Mihalis Belantis, CEO of QE2:
“This acquisition strengthens our portfolio and is aligned with QE2’s strategy: to buy and grow Alberta companies that keep Alberta growing.”
Chris Bokenfohr, GM of Candesto
“I’m excited that Candesto is now part of QE2, and I look forward to continuing to grow Candesto with the help and support of the QE2 team.”
Chris Bokenfohr, a civil engineer and owner of Candesto, will remain as General Manager of Candesto for 5 years and the existing staff is retained.
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
 
In October 2013, QE2 Acquisition Corp. completed the acquisition of Pillar Contracting Ltd.
 

PILLAR CONTRACTING LTD.
103A, 11129-83 Avenue, AB T8L 3T9
w: www.pillarltd.com
About Pillar Contracting Ltd.:
Pillar is an industry leader in specialized utilities services: maintenance of light post and street light standards, condition surveys including metal fatigue testing, flagging and traffic management. Pillar’s customers primarily consist of municipalities and utility companies. Pillar is an Alberta grown, cash flow positive business with a proven track record and a strong management team.

Mark Lacoursiere, Founder of Pillar Contracting Ltd.:
“QE2 believes in Alberta and the hardworking people that keep this province humming”, states Mark Lacoursiere. “QE2 shares my growth vision for Pillar and my belief in people and relationships. I am excited to see where Pillar will be over the next 3 years with the help of QE2. The future looks bright!”

Mihalis Belantis, CEO of QE2:
“We are proud to welcome Pillar into the QE2 family,” explains Mihalis Belantis. “Pillar’s founder, Mark Lacoursiere, and all Pillar employees are a testament to the entrepreneurial spirit, work ethic and desire to succeed that is so prevalent in Alberta!”

Company History

Albertans created QE2 Acquisition Corp. with the true Alberta spirit of determination, and the desire to create opportunity within the local economy through innovative vision and hard work.

It was an idea six years in the making, formed while living and working within the province’s rural towns and urban centers.The relationships that were forged during this period would eventually culminate to form QE2 – from influential finance professionals to research analysts, salespeople and marketers, to business owners and families.

QE2 is a company forged by a group of organized, motivated and extraordinary people with a vision to do extraordinary things.

 

 

Capitalizing On Alberta’s Growth

Tags: , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, QE2 Acquisition Corp. | Comments Off on CLIENT FEATURE: QE2 Acquisition Corp. (QE: TSX-V) Revenue Generating Infrastructure Play Capitalizing on the Alberta Advantage

INTERVIEW Part 2: Avalon Rare Metals (AVL: TSX) 3 Advanced Stage Projects Capitalizing on Scarce Rare Earth Elements

Posted by AGORACOM-JC at 1:20 PM on Wednesday, December 10th, 2014

AVL: TSX, AVL: NYSE MKT

  • Three advanced stage projects
  • Nechalacho Deposit is exceptional in its size and enrichment in the scarce “heavy” rare earth elements
  • HREE-rich resource in the Basal Zone contains Measured and Indicated Resources of 61.90 million tonnes grading 1.64% TREO (total rare earth oxides) and 21.53% HREO/TREO (heavy rare earth oxides as a percentage of TREO) at the Base Case US$345 Net Metal Return cut-off value
  • Key to enabling advances in clean technology and other growing high-tech applications

Highlights

  • The Nechalacho deposit is rich in the heavy rare earths, which the European Union identified as the critical raw material with the greatest supply risk in May 2014.
  • Avalon has invested approximately $100 million into the Nechalacho Project to date, including $60 million to complete a comprehensive Feasibility Study. Nechalacho is now the most advanced heavy rare earth project in the world outside of China. Results of the discounted cash flow analysis produced for the April 2013 Feasibility Study yielded a pre-tax IRR of 22.5% and an NPV at a 10% discount rate of $1.35 billion, with a payback period of 4.3 years and a $1.575 billion capital cost.
  • Many opportunities were identified in the April 2013 Feasibility Study to optimize the project development model to reduce technical risk and increase revenues. These include improving rare earth recoveries and revising the mine plan to improve operational efficiencies. The most significant optimization was the development of a new hydrometallurgical process that increases recoveries of the heavy rare earths while suppressing recovery of low-value cerium. An updated Feasibility Study is targeted for completion in late 2014.
  • Avalon holds a diverse rare metals project portfolio, including advanced tin (East Kemptville) and lithium minerals (Separation Rapids) properties.
  • The principles of sustainability, environmental and social responsibility are core values of the company.

Corporate Website

Tags: , , , ,
Posted in All Recent Posts, Avalon Rare Metals, Avalon Rare Metals Inc. | Comments Off on INTERVIEW Part 2: Avalon Rare Metals (AVL: TSX) 3 Advanced Stage Projects Capitalizing on Scarce Rare Earth Elements

« Older Entries
Newer Entries »